Franklin Biotechnology Discovery Fund Z(acc)GBP

Performance History31/08/2020
Growth of 1,000 (GBP) Advanced Graph
Franklin Biotechnology Discovery Fund Z(acc)GBP
Fund-1.27.2-10.929.29.9
+/-Cat2.7-3.1-3.09.0-4.3
+/-B’mrk4.9-3.9-7.78.9-1.9
 
Key Stats
NAV
18/09/2020
 GBP 42.38
Day Change 0.76%
Morningstar Category™ Sector Equity Biotechnology
IA (formerly IMA) Sector -
ISIN LU0774687577
Fund Size (Mil)
31/08/2020
 USD 1954.05
Share Class Size (Mil)
31/08/2020
 GBP 5.76
Max Initial Charge -
Ongoing Charge
24/01/2020
  1.32%
Morningstar Research
Analyst Report

Team changes and a strategy without an edge keep Franklin Biotechnology Discovery’s Morningstar Analyst Rating at Neutral.The lead here is a biotech sector fund veteran, but his supporting cast has rotated in recent years. Evan McCulloch’s 1997...

Click here to read this analyst report on the underlying fund.
Morningstar Pillars
PeopleAverage
ParentAverage
ProcessAverage
Performance
Price
Investment Objective: Franklin Biotechnology Discovery Fund Z(acc)GBP
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns (GBP)18/09/2020
YTD20.09
3 Years Annualised9.57
5 Years Annualised6.90
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Wendy Lam
01/09/2018
Click here to see others
Inception Date
04/05/2012
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Franklin Biotechnology Discovery Fund Z(acc)GBP31/08/2020
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock89.440.0089.44
Bond0.000.000.00
Property0.000.000.00
Cash9.870.009.87
Other0.690.000.69
Top 5 Regions%
United States88.60
United Kingdom3.57
Eurozone2.59
Asia - Emerging2.44
Canada1.61
Top 5 Sectors%
Healthcare98.80
Financial Services1.20
Top 5 HoldingsSector%
Regeneron Pharmaceuticals IncHealthcareHealthcare6.85
Vertex Pharmaceuticals IncHealthcareHealthcare6.36
Amgen IncHealthcareHealthcare5.46
Illumina IncHealthcareHealthcare4.25
Biogen IncHealthcareHealthcare4.00
Franklin Biotechnology Discovery Fund Z(acc)GBP

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies